Monday, February 16, 2026 2/16/2026

MRI-based Quantitative Brain Oximetry for Sickle Cell Disease

Award Number: K25HL145129
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 01/01/2019
PERIOD OF PERFORMANCE END DATE: 12/05/2021

Group Awards By:

View Award Description

MRI-based Quantitative Brain Oximetry for Sickle Cell Disease - Project Abstract: SCD is a genetic blood disorder characterized by abnormal hemoglobin S (HbS) synthesis with sickle cell anemia (SCA) as the most common subtype. Stroke is the most frequent cause of death and long-term disability in both children and adults with SCD. Studies of patients with focal neurologic deficits have revealed abnormalities of both large and small vessels in SCD. Currently, the main clinical screening test is the use of transcranial Doppler (TCD) for neurologically asymptomatic children with SCD. The TCD test is not effective to screen stroke risk in adult SCD patients. Cerebral oxygen extraction fraction (OEF), the ratio between oxygen consumption and delivery, has been recognized as a potentially more sensitive and specific indicator of cerebrovascular impairment in SCD. OEF measurement based on T2-oximetry MRI is promising as it does not require a contrast agent and is free of radiation. The existing T2-oximetry MRI techniques are not yet able to reliably measure the blood oxygenation in small veins. However, the blood oxygenation in these small veins is more sensitive to local neurological vasopathology. Using our recently developed velocity-selective MR angiography technique (that preserves high blood signal while suppressing tissue signal), we aim to fill this gap by developing a fast and reliable protocol for quantitative OEF venography including the small veins. This will help to establish the role of OEF for stroke prevention among adult SCD patients. The overall objectives of this projects are: 1) to develop and validate a robust T2-oximetry MRI protocol and demonstrated its reliability, reproducibility and accuracy in healthy volunteers. 2) to build a SCD specific T2 calibration model that can reliably translate the measured MRI parameter (blood T2) to blood oxygenation. 3) to measure the whole brain and regional cerebral OEF before and after transfusion in SCD patients with a history of stroke to have a pilot study on the relationship between between OEF and the brain injury (silent cerebral infarction and stroke).


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$50,486 )
2024	2021	HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC.	707 N BROADWAY	BALTIMORE	MD	21205	BALTIMORE CITY	USA	Blood Diseases and Resources Research	000	3	10/11/2023	NON-COMPETING CONTINUATION	-$50,486
														Subtotal = -$50,486

Issue Date FY: 2023 ( Subtotal = -$151,508 )
2023	2022	HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC.	707 N BROADWAY	BALTIMORE	MD	21205	BALTIMORE CITY	USA	Blood Diseases and Resources Research	000	4	8/16/2023	NON-COMPETING CONTINUATION	-$151,508
2023	2021	HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC.	707 N BROADWAY	BALTIMORE	MD	21205	BALTIMORE CITY	USA	Blood Diseases and Resources Research	001	3	8/17/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = -$151,508

Issue Date FY: 2022 ( Subtotal = $151,508 )
2022	2022	HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC.	707 N BROADWAY	BALTIMORE	MD	21205	BALTIMORE CITY	USA	Blood Diseases and Resources Research	000	4	1/1/2022	NON-COMPETING CONTINUATION	$151,508
														Subtotal = $151,508

Issue Date FY: 2021 ( Subtotal = $151,843 )
2021	2021	HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC.	707 N BROADWAY	BALTIMORE	MD	21205	BALTIMORE CITY	USA	Blood Diseases and Resources Research	000	3	12/24/2020	NON-COMPETING CONTINUATION	$151,843
														Subtotal = $151,843

Issue Date FY: 2020 ( Subtotal = $152,199 )
2020	2020	HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC.	707 N BROADWAY	BALTIMORE	MD	21205	BALTIMORE CITY	USA	Blood Diseases and Resources Research	000	2	12/20/2019	NON-COMPETING CONTINUATION	$152,199
														Subtotal = $152,199

Issue Date FY: 2019 ( Subtotal = $152,550 )
2019	2019	HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC.	707 N BROADWAY	BALTIMORE	MD	21205	BALTIMORE CITY	USA	Blood Diseases and Resources Research	000	1	12/31/2018	NEW	$152,550
														Subtotal = $152,550

Grand Total All Awards = $406,106

Top

All Categories

About

Search

Reports

Data Submission

Award Information

MRI-based Quantitative Brain Oximetry for Sickle Cell Disease

Award Number: K25HL145129

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 01/01/2019

PERIOD OF PERFORMANCE END DATE: 12/05/2021

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer